IRBSOTCHealthcare · Biotechnology

IR Biosciences Holdings Inc.

$0.00+0.00%(+$0.00)

TickerSpark Score

35/100

Weak

Profitability

Growth

Health

Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IRBS research report →

52-Week Range100% of range

Low $0.00

Current $0.00

High $0.00

Company

IR BioSciences Holdings, Inc. operates as a development stage biotechnology company in the United States. The company, through its subsidiary, ImmuneRegen BioSciences, Inc.

CEO: Chet Leach D.A.B.T.
IPO: 2023
Employees: 4
HQ: Scottsdale, US

Price Chart

+5900.00% · this period

Valuation

Market Cap: $128.12K
P/E: -0.00
P/S: 0.00
P/B: -0.00
EV/EBITDA: -1.06
Div Yield: 0.00%

Profitability

Gross Margin: 0.00%
Op Margin: 0.00%
Net Margin: 0.00%
ROE: 47.28%
ROIC: 101.95%

Growth & Income

Revenue: $0 · 0.00%
Net Income: $-5,278,000 · 18.34%
EPS: $-0.31 · 36.73%
Op Income: $-2,860,000
FCF YoY: 85.05%

Performance & Tape

52W High: $0.00
52W Low: $0.00
50D MA: $0.00
200D MA: $0.00
Beta: 5.01
Avg Volume: 53.37K

Get TickerSpark's AI analysis on IRBS

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

Date	Insider	Role	Type	Shares	Value
Aug 19, 09	ZELDIS JEROME B	director	other	35,000	$8.75K
Aug 19, 09	Hariri Robert J	director	other	200,000	$50.00K
Jun 23, 09	Hariri Robert J	director	other	100,000	$0
May 28, 09	Hariri Robert J	director	other	100,000	$17.00K
Aug 1, 07	Hariri Robert J	director	other	1,000,000	$166.00K
Mar 31, 08	ZELDIS JEROME B	director	other	250,000	$16.50K
Nov 26, 08	ZELDIS JEROME B	director	other	75,000	$11.25K
Nov 1, 07	ZELDIS JEROME B	director:	other	0	—